Investors remain concerned about the situation in the bond markets. Last week, Fed Chairman Jerome Powell was able to calm the markets somewhat, but yesterday
The US stock indexes were traded in small ranges on January 12. The S&P 500 has risen symbolically by 0.04% to 3801 points, with the
Mereo BioPharma Group plc (MREO) stock plunged -7.78% to $3.32 in the pre-market trading after declaring collaboration and license agreement with Ultragenyx Pharmaceutical Inc. (RARE),
The new shareholder of Exxon Mobil Corporation (XOM) is seeking to force the company to pay more attention to green energy. As the new activist
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.